Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Progression of Hospitalized Community Acquired Pneumonia - Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis in Patients With More Severe Preexisting Diseases and Immunosuppression to Complement the PROGRESS CAP Cohort

NCT05688774 is registered in ClinicalTrials.gov with Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps as lead sponsor.

NCT NCT05688774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05688774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Progression of Hospitalized Community Acquired Pneumonia - Genetic Resistance and Susceptibility for the Evolution of Severe Sepsis in Patients With More Severe Preexisting Diseases and Immunosuppression to Complement the PROGRESS CAP Cohort
Lead sponsor
Pneumonia Research Network on Genetic Resistance and Susceptibility for the Evolution of Severe Seps
Phase
Observational
Overall status
Recruiting
Start date
February 28, 2022
Completion date
February 28, 2028
Enrollment
300 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

pneumonia, sepsis, shock, septic